Finance

Lists
Why is ANIK up 2,62%?
Dive Deeper
ANIK:NASDAQ
Anika Therapeutics Inc
20,78 USD
+2,62%
(+0,53) 1D
15-окт., 14:04:56 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANIK...
Open
20,41 USD
High
20,91 USD
Low
20,31 USD
Mkt. cap
278,10 млн
Avg. vol.
89,36 миң
Volume
45,10 миң
52-wk high
22,88 USD
52-wk low
8,67 USD
EPS
-0,27 USD
Beta
0,21
Shares outstanding
13,38 млн
No. of employees
235
Open
20,41 USD
High
20,91 USD
Low
20,31 USD
Mkt. cap
278,10 млн
Avg. vol.
89,36 миң
Volume
45,10 миң
52-wk high
22,88 USD
52-wk low
8,67 USD
EPS
-0,27 USD
Beta
0,21
Shares outstanding
13,38 млн
No. of employees
235
News stories
From web sources and news partners
About Anika Therapeutics Inc
CEO-
Employees235
Founded1983
HeadquartersБедфорд, Массачусетс, Америка Кошмо Штаттары
Sector-
Websiteanika.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANIK in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANIK in the last 3 months.
Highest
Current 20,78 USD
23,00 USD (+10,68%)
Average
23,00 USD (+10,68%)
Lowest
23,00 USD (+10,68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
23,00 USD
+10,7%
10/01/2026
Madison Elsaadi
B. Riley Securities
Buy
Initiated
23,00 USD
+10,7%
09/18/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
21,00 USD
+1,1%
07/30/2026
Last report
2026-ж., 29-июл.
Fiscal period
Q2 2026
0,42 USD / 0,03 USD
+1 300,00%beat
Revenue / Est. (USD)
32,61 млн / 29,21 млн
+11,62%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
27,82 млн
30,62 млн
29,61 млн
32,61 млн
Cost of goods sold
12,23 млн
11,44 млн
10,62 млн
11,37 млн
Cost of revenue
12,23 млн
11,44 млн
10,62 млн
11,37 млн
Research and development expenses
6,95 млн
6,45 млн
6,71 млн
7,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,87 млн
12,08 млн
16,18 млн
10,18 млн
Operating expense
18,82 млн
18,53 млн
22,90 млн
17,52 млн
Total operating expenses
31,05 млн
29,97 млн
33,51 млн
28,88 млн
Operating income
-3,23 млн
646,00 миң
-3,90 млн
3,73 млн
Other non operating income
-
-
-
-
EBT including unusual items
-2,24 млн
764,00 миң
-4,82 млн
3,38 млн
EBT excluding unusual items
-2,24 млн
764,00 миң
-3,23 млн
4,15 млн
Income tax expense
939,00 миң
-1,04 млн
235,00 миң
71,00 миң
Effective tax rate
-41,99%
-135,73%
-4,87%
2,10%
Other operating expenses
-
-
-
-
Net income
-2,33 млн
292,00 миң
-5,06 млн
3,31 млн
Net profit margin
-8,37%
0,95%
-17,07%
10,15%
Earnings per share
0,04
0,31
0,27
0,42
Interest and investment income
997,00 миң
118,00 миң
667,00 миң
426,00 миң
Interest expense
-
-
-
-
Net interest expenses
997,00 миң
118,00 миң
667,00 миң
426,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,83 млн
1,96 млн
-2,49 млн
5,23 млн
Gain or loss from assets sale
-451,00 миң
790,00 миң
-52,00 миң
-32,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору